BioSpace News Archive

Willow Biosciences Inc. (" Willow " or the " Company ") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it is undertaking two initiatives to help our customers evaluate and better understand cannabigerol (" CBG "), our first commercial cannabinoid slated for production in Q1 2021. Willow ha

KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to systematically screen the whole genome to identify optimal gene targets for oncology and autoimmune disease, today announced that it has entered into a broad strategic collaboration with Takeda Pharmaceutical Company Limited (“Takeda”) to research, develop and commercialize novel immune-based therapies for cancer.

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced it has received a positive response from the U.S. Food and Drug Administration (FDA) that the efficacy and safety data resulting from the company’s pivotal Phase 3 Marigold Study on the use of oral ganaxolone

The debut of a new U.S. based global biotechnology company, Vaxxinity, will take place at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, at 9:50 a.m. EST.

Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for HPN217 for the treatment of multiple myeloma

GenScript USA Inc., the world’s leading research reagent provider, announced today that it has submitted an application to the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) for use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit in convalescent plasma screening

Webinar to review expanded biomarker data from the company’s Phase 1b clinical trial of XPro1595 targeting neuroinflammation in patients with Alzheimer’s disease

Reflect Scientific, Inc., a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announces a $416K sales contract for Cryometrix B-90 blast freezers from a prominent pharmaceutical company.

IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) announces that the location of its annual meeting (the “Meeting”) to be held on Wednesday, January 20, 2021 has been changed to IBEX’s head office, 5485 Paré Street, Suite 100, Montreal, Québec H4P 1P7 and the time of the Meeting has been changed to 11 a.m.

Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced a multi-year collaboration with Invitae Corporation (NYSE: NVTA), a leading medical genetics company, to begin development of a production-scale high-throughput sequencing platform leveraging the power of PacBio’s highly accurate HiFi sequencing to expand Invitae’s whole genome testing capabilities. “